IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
IRadimed Corp (IRMD) Mentioned Positively at Roth Capital, 'Solid Fundamentals'
May 2, 2022 10:58 AM EDTRoth Capital analyst Scott R. Henry lowered the price target on IRadimed Corp (NASDAQ: IRMD) to $40.00 (from $53.00) while maintaining a Buy rating.
The analyst comments "IRMD reported 1Q22 results that were modestly ahead of our expectations. The key takeaways, in our opinion,... More
